EP3034512 - A process for producing iron (III) casein N-acetyl-aspartylated complexes and use thereof in pharmaceutical compositions [Right-click to bookmark this link] | Status | No opposition filed within time limit Status updated on 12.10.2018 Database last updated on 16.07.2024 | |
Former | The patent has been granted Status updated on 03.11.2017 | ||
Former | Grant of patent is intended Status updated on 18.06.2017 | ||
Former | Examination is in progress Status updated on 03.03.2017 | Most recent event Tooltip | 12.10.2018 | No opposition filed within time limit | published on 14.11.2018 [2018/46] | Applicant(s) | For all designated states Tseti, Ioulia 13 Pavlou Mela Street 145 61 Kifissia Attikis / GR | [2017/49] |
Former [2016/25] | For all designated states Tseti, Ioulia 13 Pavlou Mela Street 145 61 Kifissia Attikis / GR | Inventor(s) | 01 /
see applicant ... | [2016/25] | Representative(s) | Wibbelmann, Jobst Wuesthoff & Wuesthoff Patentanwälte und Rechtsanwalt PartG mbB Schweigerstrasse 2 81541 München / DE | [N/P] |
Former [2016/25] | Wibbelmann, Jobst Wuesthoff & Wuesthoff Patentanwälte PartG mbB Schweigerstrasse 2 81541 München / DE | Application number, filing date | 14386034.4 | 19.12.2014 | [2016/25] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | EP3034512 | Date: | 22.06.2016 | Language: | EN | [2016/25] | Type: | B1 Patent specification | No.: | EP3034512 | Date: | 06.12.2017 | Language: | EN | [2017/49] | Search report(s) | (Supplementary) European search report - dispatched on: | EP | 13.03.2015 | Classification | IPC: | C07K14/47 | [2016/25] | CPC: |
C07K14/4732 (EP,EA,IL,US);
A61K47/64 (EA,US);
A61K33/26 (EA,US)
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2016/39] |
Former [2016/25] | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR | Title | German: | Verfahren zur Herstellung von Eisen (III)-Casein-N-Acetyl-aspartylierten Komplexen und Verwendung derselben in pharmazeutischen Zusammensetzungen | [2017/49] | English: | A process for producing iron (III) casein N-acetyl-aspartylated complexes and use thereof in pharmaceutical compositions | [2016/25] | French: | Procédé de production de complexes fer (III) de la caséine N-acétyl-aspartyl et leur utilisation dans des compositions pharmaceutiques | [2016/25] |
Former [2016/25] | Verfahren zur Herstellung von (III)-Kasein-n-acetyl-aspartylierten Komplexen und Verwendung davon in pharmazeutischen Zusammensetzungen | Examination procedure | 12.08.2016 | Amendment by applicant (claims and/or description) | 12.08.2016 | Examination requested [2016/39] | 02.03.2017 | Despatch of a communication from the examining division (Time limit: M04) | 06.04.2017 | Reply to a communication from the examining division | 19.06.2017 | Communication of intention to grant the patent | 18.10.2017 | Fee for grant paid | 18.10.2017 | Fee for publishing/printing paid | 18.10.2017 | Receipt of the translation of the claim(s) | Opposition(s) | 07.09.2018 | No opposition filed within time limit [2018/46] | Fees paid | Renewal fee | 20.12.2016 | Renewal fee patent year 03 |
Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [XD]EP0243322 (MAGIS FARMACEUTICI [IT]) [XD] 6 * the whole document, in particular the claims *; | [XD]WO2006021843 (BIOFER SPA [IT], et al) [XD] 6 * the whole document, in particular p. 4, Example 2 and claims 6-10 *; | [AD] - LAZZARI FLAVIO ET AL, "Overview of clinical trials in the treatment of iron deficiency with iron-acetyl-aspartylated casein", CLINICAL DRUG INVESTIGATION, (2005), vol. 25, no. 11, ISSN 1173-2563, pages 679 - 689, XP009182971 [AD] 1-6 * the whole document * DOI: http://dx.doi.org/10.2165/00044011-200525110-00001 | [AD] - BURON ET AL, "On the racemisation of aspartic anhydride during its preparation", TETRAHEDRON ASYMMETRY, PERGAMON PRESS LTD, OXFORD, GB, (20070717), vol. 18, no. 13, doi:10.1016/J.TETASY.2007.07.003, ISSN 0957-4166, pages 1625 - 1627, XP022181932 [AD] 1-6 DOI: http://dx.doi.org/10.1016/j.tetasy.2007.07.003 | by applicant | GB910321 | US4493829 | EP0243322 | EP0939083 | US2001031748 | WO2006021843 | - CREMONESI P ET AL., ARZNEIMITTEL-FORSCHUNG, (1984), vol. 34, no. 9, page 948 952 | - REMONESI P ET AL., INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY, THERAPY, AND TOXICOLOGY, vol. 31, no. 1, pages 40 - 51 | - LAZZARI ET AL., CLINICAL DRUG INVESTIGATION, (2005), vol. 5, no. 11, pages 679 - 689 | - TETRAHEDRON: ASYMMETRY, (2007), vol. 18, pages 1625 - 1627 | - "Iron derivatives of modified milk protein", ARZNEIMITTEL-FORSCHUNG, (1984), vol. 34, no. 9, pages 948 - 952 | - INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY, THERAPY, AND TOXICOLOGY, (199901), vol. 31, no. 1, pages 40 - 51 | - "Overview of clinical trials in the treatment of iron deficiency with iron acetyl-aspartylated casein", CLINICAL DRUG INVESTIGATION, (2005), vol. 2, no. 11, pages 679 - 689 | - TETRAHEDRON: ASYMMETRY, (2007), vol. 18, pages 1625 - 27 |